← back to search

Hans F. A. Vasen

Kliniken Essen-Mitte · NL
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Since 1985, Professor Hans Vasen is staff member of the Department of Gastroenterology & Hepatology of the Leiden University Medical Centre (LUMC) as well as Medical Director of the Dutch Hereditary Cancer Registry. In 2000, Vasen received the Frieda den Hartog Jager Penning (Dutch Association Gastroenterology & Hepatology). In 2017, his study , “ Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. ” was selected for inclusion in the JCO's report, Clinical Cancer Advances 2017: ASCO’s Annual Report on Progress Against Cancer . The report is an independent annual review of the year’s major achievements and emerging trends in clinical cancer research and care.
h-index
110
citations
49,198
works
602
NIH funding
primary concept
email

Recent publications

Progress Report: New insights into the prevention of CRC by colonoscopic surveillance in Lynch syndrome.
2022cited by 7position: contributordoi
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
European Journal of Cancer 2021cited by 21position: middledoi
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study
Journal of Clinical Medicine 2021cited by 19position: middledoi
Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome
Gastroenterology 2020cited by 101position: lastdoi
The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance
International Journal of Cancer 2020cited by 96position: middledoi
Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
Genetics in Medicine 2020cited by 41position: middledoi
Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019
Familial Cancer 2020cited by 24position: lastdoi
Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Genetics in Medicine 2020cited by 10position: middledoi
Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries
Familial Cancer 2020cited by 9position: middledoi
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Genetics in Medicine 2019cited by 638position: middledoi
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
Gut 2019cited by 610position: middledoi
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
European Urology 2019cited by 235position: middledoi
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report
Hereditary Cancer in Clinical Practice 2019cited by 63position: middledoi
Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy.
2019cited by 43position: contributordoi
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.
2019cited by 42position: contributordoi
Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps.
2019cited by 9position: contributordoi
Surveillance for familial melanoma: recommendations from a national centre of expertise.
2019cited by 7position: contributordoi
No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies
Gastroenterology 2018cited by 150position: middledoi
Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy
Journal of Medical Genetics 2018cited by 58position: middledoi
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
British Journal of Cancer 2018cited by 19position: middledoi
Cancer risk and survival in <i>path_MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
Gut 2017cited by 564position: middledoi
Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report
Hereditary Cancer in Clinical Practice 2017cited by 62position: middledoi
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
Gut 2016cited by 167position: middledoi
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Gut 2015cited by 544position: middledoi
Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study
Journal of Clinical Oncology 2015cited by 121position: middledoi
Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents
Gastroenterology 2015cited by 96position: middledoi
Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer
Scientific Reports 2015cited by 25position: middledoi
Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD)
Journal of Medical Genetics 2014cited by 469position: middledoi
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
European Urology 2014cited by 248position: middledoi
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D)
Journal of Medical Genetics 2014cited by 202position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Chrystelle Colas · Université Paris Cité4 papers (2014–2020)Yael Goldberg · Hebrew University of Jerusalem4 papers (2014–2020) · 4 papers (2014–2020) · 4 papers (2014–2020)Frederik J. Hes · Princess Máxima Center3 papers (2014–2019) · 3 papers (2014–2020)Christian P. Kratz · Medizinische Hochschule Hannover3 papers (2014–2018)Maartje Nielsen · The Netherlands Cancer Institute3 papers (2019–2019) · 3 papers (2014–2020)Natacha Entz‐Werlé · Centre National de la Recherche Scientifique2 papers (2014–2014)Annika Lindblom · Melbourne Health2 papers (2014–2015)Irene Slavc · Universitätsklinik für Kinder und Jugendpsychiatrie2 papers (2014–2018)Tim Ripperger · Medizinische Hochschule Hannover2 papers (2018–2020) · 2 papers (2014–2014) · 2 papers (2014–2014)Alex Duval · Inserm2 papers (2014–2014) · 2 papers (2014–2014)Maartje Nielsen · University of Kentucky2 papers (2014–2018)Inge Bernstein · Aalborg University Hospital2 papers (2014–2019)Fred H. Menko · University Hospital Heidelberg2 papers (2014–2018)